Alan Employer Platform
Automated HR platform for managing employee health insurance and benefits
Platform · Cloud SaaSCompany source
Company profile
About Alan
Alan is a digital health insurance and wellness company that has reimagined healthcare delivery across Europe and North America. Founded in 2016 as the first new health insurance player licensed in France since 1986, Alan has rapidly grown to serve over 1 million members and 37,000 businesses across four countries: France, Spain, Belgium, and Canada. The company provides an integrated model combining health insurance, prevention programs, and daily care services through a highly-rated mobile application (4.9/5 stars). Alan's platform offers exceptional customer service with 20-second average phone response times and 99% of reimbursements processed within one day, with 70% completed in under an hour. The company's innovative services include the Clinique Alan virtual clinic available 7/7, personalized prevention plans through Alan Play (a gamified wellness program), an online optical center, and access to 80+ healthcare professionals. Alan serves diverse customer segments including self-employed workers (TNS), startups, SMEs, large enterprises, retirees, and students. The company emphasizes prevention and employee wellbeing, helping organizations reduce absenteeism and improve productivity. With 790+ employees and €804 million in annual recurring revenue as of Q1 2026, Alan is valued at €5.5 billion following a €480 million Series G funding round led by Prosus. The company maintains strong regulatory compliance and is supervised by France's ACPR (Autorité de contrôle prudentiel et de résolution).
Company description Alan official website
Primary marketTelemedicine & Virtual Care
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Alan?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Chronic disease management
- General health and wellness
- Mental health
- Occupational health
- Preventive care
Who it serves
- Large enterprises (100+ to thousands of employees)
- Public sector organizations
- Retirees
- Self-employed workers (TNS)
- SMEs (6-100 employees)
- Startups and micro-enterprises (1-5 employees)
- Students
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsBelgium · Canada · France · Spain
Company sourceOfficial website
Company milestones
Platform expansion
Series G funding of €480 million led by Prosus in 2025, valuing company at €5.5 billion. Reached €804 million ARR in Q1 2026. Surpassed 1 million members and 37,000 business clients. Launched Shop, Walk, Mo innovations. Signed major strategic partnership with Belfius.
Partnerships
Recorded partners
- Almerys (third-party payment processor)
- Belfius (major strategic partnership)
- Expert-comptable partners
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Alan Health Insurance
Integrated health insurance, prevention, and daily care platform
Platform · Cloud SaaSCompany source
Alan Mobile App
4.9/5 rated health management app with instant reimbursements
Software · Cloud SaaSCompany source
Alan Play
Gamified wellness program driving employee engagement and healthy habits
Platform · Cloud SaaSCompany source
Clinique Alan (Alan Clinic)
Virtual clinic with 80+ healthcare professionals available 7/7
Service · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Conformal uncertainty quantification to evaluate predictive fairness of foundation AI model for skin lesion classes across patient demographics.Health information science and systems · Dec 1, 2026
Weaving phosphorus-doped Co3O4 nanozyme: a colorimetric detection platform for total antioxidant capacity.Analytica chimica acta · Oct 15, 2026
Glial cells in neuropathic pain.Physiological reviews · Oct 1, 2026
Probing electron pathways to multicopper oxidase copper centers reveals shortcut for enhancing oxygen reduction reaction.Bioelectrochemistry (Amsterdam, Netherlands) · Oct 1, 2026
Multiple regulatory roles of UNC93B1 in innate immunity.Cellular signalling · Oct 1, 2026
Dual metal synergy promotes electrocatalytic nitrate-to-ammonia conversion in neutral electrolyte.Journal of colloid and interface science · Sep 15, 2026
Clinical validation
Clinical-trial records
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296 · Mentioned · RECRUITING
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNCT05675410 · Mentioned · RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseaseNCT05174169 · Mentioned · RECRUITING
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.NCT06917404 · Mentioned · ACTIVE NOT RECRUITING
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLNCT06500273 · Mentioned · RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsNCT06112418 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
3x higher employee retention
Companies investing in employee wellbeing
2x more likely to exceed growth objectives
Companies with strong wellbeing programs
10x more likely to maintain lower absenteeism
Compared to industry sector averages
98% of client companies spend less than 2 hours per year managing health insurance
Based on 2023 platform usage
80% of employers observe better team cohesion
Through Alan Play wellness program
+20,000 steps per month per user on average
Alan Play users as of June 2025
50% of members no longer need consultation after Clinique Alan conversation
December 2023 member survey
92% member satisfaction rate
May 2025
20 second average phone response time
90% of cases
99% reimbursements within one day, 70% in under 1 hour
Overall platform performance
TooGoodToGo France
Addressing sedentary lifestyle issues and boosting team cohesion through Alan Play wellness program
Improved team cohesion and employee engagement through gamified wellness challenges
Bleu Libellule
Implementing employee well-being programs to drive business outcomes and ROI
Demonstrated that well-being generates measurable return on investment for 1200 employees
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Charles Gorintin
Publishing Director
06 · Company updates
Updates from Alan
Recent articles published on Alan's official website.
Healthier Humanity podcast #22 - Arrêt cardiaque : comment doubler vos chances de survie - Dr. Walid Amara
Read on AlanNos derniers articles
Read on AlanAlan étend son modèle d'assurance prévention à l'Afrique de l'Ouest avec l'acquisition de Tanel
Read on AlanHealthier Humanity podcast #23 - Vivre avec une maladie chronique : les secrets d'un médecin malade depuis 29 ans - Dr. Charlotte Tourmente
Read on AlanIncident de sécurité chez notre prestataire de tiers-payant
Read on Alan07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
India Rewrites the Rulebook for Stem Cell Therapies and Essential Drug Pricing in Landmark Healthcare Reform
New regulatory framework brings gene and cell therapies under formal oversight while controversial pricing changes could reshape access to essential medicines
Policy & Regulation · Jul 3, 2026
Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
A groundbreaking UK study demonstrates that early intervention with an existing drug can prevent the onset of debilitating autoimmune disease in high-risk patients, opening the door for AI-powered predictive screening.
Clinical AI · Jul 3, 2026
Million-Heart Dataset Deal Positions Australian Startup at Forefront of AI Cardiac Diagnostics Race
EchoIQ's exclusive access to up to one million echocardiogram scans represents one of the largest cardiovascular imaging datasets secured for AI development in the Asia-Pacific region.
Clinical AI · Jul 3, 2026
The Circadian Surgery Revolution: Why Your Heart Operation Time Might Matter as Much as Your Surgeon
Afternoon cardiac surgeries show significantly less heart muscle damage than morning procedures, as researchers discover our internal biological clocks may influence how patients respond to operations.
Clinical AI · Jul 2, 2026
Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Mechanistic AI that explains *why* drugs work—rather than just predicting outcomes—could finally give regulators the transparency needed to accelerate drug development and reduce catastrophic trial failures.
Drug Discovery & Research · Jun 26, 2026
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Policy & Regulation · Jun 18, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Telemedicine & Virtual Care
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.